Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FD9NW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,845
Award facts
- Contract value 100% obligated
- $7,845.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,845.19 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injectors, with an ultimate completion date of September 22, 2025. This firm fixed price contract, awarded September 19, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to supply medications, vaccines, and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal pharmaceutical contracts with the Defense Logistics Agency, covering a broad spectrum of therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This award for Zepbound, a GLP-1 receptor agonist diabetes medication, reflects the company's ongoing role in supplying brand-name pharmaceutical products through the DLA's medical supply chain to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FD9NW?
SPE2DB25FD9NW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FD9NW worth?
The government has obligated $7,845 on SPE2DB25FD9NW.
Is contract SPE2DB25FD9NW an order under another contract?
Yes. SPE2DB25FD9NW is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD9NW competed?
The extent of competition for SPE2DB25FD9NW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award